Molecular Devices acquires Cellesce

“This enabling technology will make over 100,000 compound primary screens with PDOs a reality and will accelerate industry adoption of organoids”

19-Dec-2022 - Molecular Devices, LLC. announced the acquisition of Cellesce Ltd which specializes in contract development and manufacturing of large scale patient-derived organoids (PDOs) for diverse applications, including drug screening. Drug efficacy and toxicity testing often rely on immortalized cell ...

Molecular Devices and life science start-up cytena expand their partnership

New CloneSelect Single-Cell Printer products

15-May-2019 - Molecular Devices, LLC announced an expansion in its partnership with cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ Series in North America. Building on their success of the CloneSelect™ Single-Cell Printer™ SCP™ system, the new family evolves both the ease of use for image-based ...

Molecular Devices and Cytena Partner collaborate in single cell printing

20-Sep-2017 - Molecular Devices, LLC announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This system utilizes microfluidics-based technology and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for use in ...

Molecular devices wins patent case in Europe

07-Oct-2016 - Molecular Devices, LLC announced that its European Patent No. 1802752 titled “Parallel Patch Clamp System” was upheld by the European Patent Office in its original form, following a recent Opposition Proceeding. Molecular Devices’ patent went through Opposition Proceedings before the ...